Mandate

Vinge has assisted Priveq in connection with the formation of Priveq Investment VII

June 04, 2024 Private Funds

Priveq, a leading Nordic lower mid-market growth and buyout investor, has closed its seventh fund, Priveq Investment VII, at SEK 3 billion. The fund’s first and final closing was significantly oversubscribed with strong backing from existing investors and substantial interest from new institutional investors.


The fund’s investor base consists of a diversified group of Nordic, European and North American investors including public and private pension funds, insurance companies, charitable foundations, endowments, public institutions, family offices and fund-of-funds.

Vinge has assisted Priveq as Swedish legal counsel in connection with the fund formation.

Vinge's team consisted of Mattias Schömer, Marcus Andersson, Nils Unckel, Anton Sjökvist, Emelie Svanberg, Tobias Onegård Karlsson, Semir Omerbasic, Emelie Zingmark, Helena Göransson, Nour Makie and Elias Kröger.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025